Share

November 14, 2020

"The Sars-CoV2 virus changes up to 100 times less than HIV. This raises the hope of developing effective vaccines."

This was stated by Maria Rosaria Capobianchi, professor of Molecular Biology and head of the Virology Laboratory of the Spallanzani Institute, who was the first to isolate the Sars-CoV2 in Italy, on the occasion of the virtual inauguration of the academic year of the UniCamillus University.

It emerges from an analysis conducted after the recent publication of Microorganism, which had highlighted a change in the virus between the upper and lower respiratory tracts. "The good news is that it has a more stable" and less elusive genome, and "it's easier to develop vaccines that work."